Form 4: Privia Health Director Thomas McCarthy Receives Equity Grant of Restricted Stock Units

Privia Health Group, Inc. Director Thomas A. McCarthy was granted 8,396 restricted stock units on May 21, 2025, as part of the company's 2021 Omnibus Incentive Plan.

Summary

• On May 21, 2025, Thomas A. McCarthy, a Director of Privia Health Group, Inc. (PRVA), received a grant of 8,396 restricted stock units (RSUs).
• The RSUs were granted under the Issuer's 2021 Omnibus Incentive Plan at a price of $0 per unit, indicating a compensation grant rather than a purchase.
• These restricted stock units are scheduled to vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders or (ii) the first anniversary of the grant date (May 21, 2025).
• Following this transaction, Mr. McCarthy's beneficial ownership of Privia Health common stock includes 19,520 shares held directly and 41,487 shares held indirectly by a Trust, totaling 61,007 shares.

Sentiment

Score: 7

Explanation: The document reports a standard equity grant to a director, which is a positive for corporate governance and alignment of interests, but does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of restricted stock units to a director aligns their interests with those of the shareholders, incentivizing long-term performance and value creation.
• This equity compensation is a standard practice for retaining and motivating key board members.

Future Outlook

The granted restricted stock units are set to vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2025), providing a future incentive for the director.

Industry Context

Equity grants, such as restricted stock units, are a common form of compensation for directors and executives across various industries, including healthcare services, to align their long-term interests with those of the company's shareholders.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a standard compensation practice in the healthcare services sector, comparable to similar equity incentive programs at companies like Teladoc Health (TDOC) or Amwell (AMWL) for their board members.
• The vesting schedule, tied to either an annual meeting or a one-year anniversary, is also a typical structure for director equity awards, aiming to ensure continued engagement and oversight.

Corporate Governance

Related Party Transactions

• The grant of restricted stock units to Thomas A. McCarthy, a director of Privia Health Group, Inc., constitutes a transaction with a related party, which is a standard form of director compensation.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's incentives with shareholder value creation, potentially leading to better long-term decision-making.
• Employees: While not directly impacting employees, the incentive plan reflects the company's broader compensation philosophy which may extend to other key personnel.

Next Steps

• The restricted stock units will vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2025).

Key Dates

Keywords

Privia Health, PRVA, SEC Form 4, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Insider Transaction, Thomas McCarthy, Omnibus Incentive Plan